Retour
4
Fourchette du Jour
47,75 €
49,34 €
Fourchette 52 Semaines
29,16 €
59,68 €
Volume
558 737
Moyenne 50J / 200J
51,14 €
/
45,13 €
Clôture Précédente
47,76 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -73,6 | 0,4 |
| P/B | 0,0 | 2,9 |
| ROE % | 0,0 | 3,8 |
| Net Margin % | -5,4 | 3,9 |
| Rev Growth 5Y % | 5,5 | 10,0 |
| D/E | 0,0 | 0,2 |
Objectif de Cours des Analystes
Hold
62,00 €
+25.9%
Low: 55,00 €
High: 65,00 €
P/E Prévisionnel
25,6
BPA Prévisionnel
1,92 €
Croissance BPA (est.)
+0,0%
CA Est.
870 M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
7,01 €
6,77 € – 7,19 €
|
1,4 B | 1 |
| FY2029 |
6,91 €
6,67 € – 7,08 €
|
1,3 B | 1 |
| FY2028 |
5,19 €
2,33 € – 8,05 €
|
1,2 B | 2 |
Points Clés
Revenue grew 5,53% annually over 5 years — modest growth
Earnings declined -152,19% over the past year
Debt/Equity of 0,03 — conservative balance sheet
Generating 45,99M in free cash flow
PEG of 0,48 suggests growth is underpriced
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 3,10%
Croissance
Revenue Growth (5Y)
5,53%
Revenue (1Y)8,63%
Earnings (1Y)-152,19%
FCF Growth (3Y)-35,49%
Qualité
Return on Equity
-0,01%
ROIC0,00%
Net Margin-5,36%
Op. Margin-5,13%
Sécurité
Debt / Equity
0,03
Current Ratio1,90
Interest Coverage0,00
Valorisation
P/E Ratio
-73,56
P/B Ratio0,00
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 8,63% | Revenue Growth (3Y) | 8,79% |
| Earnings Growth (1Y) | -152,19% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 5,53% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 718,95M | Net Income (TTM) | -38,55M |
| ROE | -0,01% | ROA | 0,00% |
| Gross Margin | 89,63% | Operating Margin | -5,13% |
| Net Margin | -5,36% | Free Cash Flow (TTM) | 45,99M |
| ROIC | 0,00% | FCF Growth (3Y) | -35,49% |
| Safety | |||
| Debt / Equity | 0,03 | Current Ratio | 1,90 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -73,56 | P/B Ratio | 0,00 |
| P/S Ratio | 3,94 | PEG Ratio | 0,48 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 2,84B | Enterprise Value | -95,25B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 718,95M | 661,82M | 607,52M | 667,24M | 579,78M |
| Net Income | -38,55M | 73,87M | 1,32M | 60,71M | 53,42M |
| EPS (Diluted) | -0,68 | 1,32 | 0,02 | 1,04 | 0,98 |
| Gross Profit | 644,39M | 583,91M | 523,74M | 580,02M | 504,71M |
| Operating Income | -36,86M | 81,67M | -5,27M | 46,12M | 86,03M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1,45T | 1,37B | 1,28B | 1,70B | 1,69B |
| Total Liabilities | 390,93B | 332,34M | 356,16M | 816,30M | 873,30M |
| Shareholders' Equity | 1,06T | 1,04B | 921,52M | 886,20M | 815,85M |
| Total Debt | 30,37B | 34,27M | 41,53M | 444,76M | 427,03M |
| Cash & Equivalents | 128,45B | 69,33M | 75,05M | 93,12M | 203,43M |
| Current Assets | 644,18B | 686,07M | 493,11M | 734,15M | 601,59M |
| Current Liabilities | 338,17B | 292,40M | 290,20M | 687,96M | 315,38M |
Scores de Stratégies
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#810 of 820
Activité Récente
Entré
Deep Value Investing (Seth Klarman)
Mar 24, 2026